Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
41.2K
-
Shares change
-
-37.4K
-
Total reported value, excl. options
-
$1.25M
-
Value change
-
-$748K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$30.44
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q4 2023
3 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q4 2023.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.2K shares
of 107M outstanding shares and own 0.04% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (17.7M shares), WELLINGTON MANAGEMENT GROUP LLP (8.2M shares), BlackRock Inc. (5.93M shares), VANGUARD GROUP INC (5.45M shares), MAVERICK CAPITAL LTD (4.03M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (3.94M shares), STATE STREET CORP (3.23M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.63M shares), CITADEL ADVISORS LLC (2.46M shares), and Avidity Partners Management LP (1.72M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.